AlanS.GoMD

Director, Comprehensive Clinical Research Unit; Regional Medical Director for Clinical Trials

Dr. Go is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Residency, Internal Medicine, 1993 - 1996
University of California San Francisco School of MedicineClass of 1993

PubMed

66 citations
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
Jeffrey M. Ashburner, Alan S. Go, Yuchiao Chang, Margaret C. Fang, Lisa Fredman
Journal of the American College of Cardiology. 2016-01-26
4932 citations
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, Donna K. Arnett, Michael J. Blaha
Circulation. 2016-01-26
1252 citations
Large-scale association analysis identifies new risk loci for coronary artery disease
Panos Deloukas, Stavroula Kanoni, Christina Willenborg, Martin Farrall, Themistocles L. Assimes
Nature Genetics. 2013-01-01

Journal Articles

Timing of Dialysis Initiation and End-Stage Kidney Disease Incidence—Reply
Alan Go, MD, JAMA Internal Medicine
Implication of Trends in Timing of Dialysis Initiation for Incidence of End-Stage Kidney Disease
Chi-Yuan Hsu, Leonid N Pravoverov, Alan S Go, JAMA Internal Medicine
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction
Matthew D Solomon, Edward J McNulty, Jamal S Rana, Stephen Sidney, Alan S Go, The New England Journal of Medicine
Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals
Stephen Sidney, Marc G Jaffe, Jamal S Rana, Alan S Go, JAMA
Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation
Daniel E Singer, Mark H Eckman, Alan S Go, Annals of Internal Medicine
Multimorbidity Burden and Adverse Outcomes in a Community‐Based Cohort of Adults with Heart Failure
David J Magid, Jerry H Gurwitz, David H Smith, Alan S Go, Journal of the American Geriatrics Society
Thromboprophylaxis for Patients with High-Risk Atrial Fibrillation and Flutter Discharged from the Emergency Department
Dustin G Mark, Alan S Go, David S Glaser, David R Vinson, Uli K Chettipally, Sean Z Bouvet, Patricia C Ramos, UC Open Access Publications
Join now to see all

The Covid-19 Pandemic and the Incidence of Acute Myocardial InfarctionMay 2020
The Covid-19 Pandemic and the Incidence of Acute Myocardial InfarctionMay 2020
Comparative Trends in Heart Disease, Stroke, and All-Cause Mortality in the United States and a Large Integrated Healthcare Delivery SystemApril 2018
Comparative Trends in Heart Disease, Stroke, and All-Cause Mortality in the United States and a Large Integrated Healthcare Delivery SystemApril 2018
Join now to see all

Prospective Evaluation Of Acute Kidney Injury (PEAK) CohortNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Chronic Renal Insufficiency Cohort Study IINational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
HMO Research Network Cardiovascular Research NetworkNational Heart, Lung, And Blood Institute2007–2011
Management And Outcomes Of Heart Failure With Preserved Systolic FunctionNational Heart, Lung, And Blood Institute2009–2010
Contemporary Treatment And Outcomes For Atrial Fibrillation In Clinical PracticeNational Heart, Lung, And Blood Institute2009–2010
Prospective Evaluation Of Acute Kidney Injury (PEAK) CohotNational Institute Of Diabetes And Digestive And Kidney Diseases2008
Study Of The Care And Outcomes Of Renal InsufficiencyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2008
Patient-Clinician Factors Influencing Racial/Ethnic Variation In Coronary DiseaseAgency For Healthcare Research And Quality2000–2002